| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in IONS over the last quarter tilts toward selling: insiders offloaded a net 1,410 shares worth roughly $61K. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 242.8K | $9.68M | - | |
| Dir | 161.2K | $6.43M | - | |
| VP | 102.9K | $4.10M | - | |
| CFO | 82.7K | $3.30M | - | |
| VP | 77.1K | $3.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Joseph H Wender57 | Director | Sell10b5-1 | 28,000 | $57.58 | $1,612,155.44 | -20.5% | +34.4% | -3.9% | |
| Sep 3, 2025 | Joseph H Wender57 | Director | Sell10b5-1 | 28,000 | $57.58 | $1,612,155.44 | -20.5% | +34.4% | -3.9% | |
| Sep 2, 2025 | Richard S Geary66 | EVP, Chief Development Officer | Sell10b5-1 | 10,000 | $50.37 | $503,671.00 | -11.2% | +42.6% | +6.7% | |
| Sep 2, 2025 | B Lynne Parshall72 | Director | Sell10b5-1 | 20,000 | $50.91 | $1,018,297.50 | -23.2% | +42.6% | +6.7% | |
| Sep 2, 2025 | Eric Swayze67 | EVP Research | Sell10b5-1 | 11,130 | $49.67 | $552,861.68 | -23.0% | +42.6% | +6.7% | |
| Aug 22, 2025 | Allene M. Diaz45 | Director | Sell10b5-1 | 1,427 | $42.53 | $60,687.17 | -7.2% | +71.3% | +39.9% | |
| Aug 18, 2025 | C Frank Bennett64 | EVP, Chief Scientific Officer | Sale+OE10b5-1 | 10,000 | $43.98 | $439,776.00 | -9.7% | +68.7% | +37.3% | |
| Aug 6, 2025 | B Lynne Parshall72 | Director | Sell10b5-1 | 5,000 | $41.93 | $209,646.10 | -5.5% | +79.1% | +33.9% | |
| Aug 5, 2025 | Richard S Geary66 | EVP, Chief Development Officer | Sell10b5-1 | 10,000 | $42.86 | $428,593.00 | -10.1% | +71.1% | +25.9% | |
| Aug 4, 2025 | Eugene Schneider63 | EVP, Chf Clinical Develop Officer | Sell10b5-1 | 9,549 | $42.80 | $408,701.02 | -15.6% | +69.5% | +26.7% |